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OBJECTIVE — Recently, it has been suggested that insulin resistance and hyperinsulinemia
can exist in isolation and have differential impacts on cardiovascular disease (CVD). To evaluate
this suggestion, we assessed the degree of discordance between insulin sensitivity and insulin
response in a healthy, nondiabetic population.
RESEARCH DESIGN AND METHODS — Insulin sensitivity was quantiﬁed by deter-
mining the steady-state plasma glucose (SSPG) concentration during an insulin suppression test
in 446 individuals. The integrated insulin response was calculated after a 75-g oral glucose
challenge. We analyzed the correlation between insulin resistance and insulin response in ad-
dition to quantifying the proportion in quartiles of insulin response by quartiles of insulin
sensitivity. Then we compared CVD risk factors between individuals within the same insulin
sensitivity quartile but within different insulin response quartiles to evaluate the differential
clinical impact of insulin resistance and hyperinsulinemia.
RESULTS — Insulin resistance and insulin response were highly correlated (r  0.76, P 
0.001). A majority (95%) of the most insulin-resistant individuals (top SSPG quartile) were
either in the highest insulin response quartile (71%) or second highest (24%). Similarly, 92% of
the most insulin-sensitive individuals (lowest SSPG quartile) were in the lowest two insulin
responsequartiles.TherewereminimaldifferencesinCVDriskfactorsbetweenindividualswith
different insulin responses but within the same insulin sensitivity quartile.
CONCLUSIONS — Although not perfectly related, insulin resistance and hyperinsulinemia
rarely exist in isolation in a nondiabetic population. It is difﬁcult to discern an independent
impact of hyperinsulinemia on CVD risk factors associated with insulin resistance.
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I
n nondiabetic individuals, a hyperin-
sulinemic response to an oral glucose
challenge is closely associated with de-
creases in insulin-mediated glucose up-
take (1–3), as well as with a number of
clinical syndromes associated with insu-
lin resistance (4–10). However, the rela-
tionship is not perfect, and there have
been several attempts to differentiate be-
tween the relative roles of insulin resis-
tance and hyperinsulinemia in the
development of clinical syndromes asso-
ciated with these changes in insulin me-
tabolism (11–14). For example, in a
recent article, Ferrannini et al. (14) indi-
cated in a large European population that
only 60% of the most insulin-resistant in-
dividuals (bottom quartile of insulin sen-
sitivity measured by the euglycemic
insulin clamp) had the highest insulin re-
sponse (top quartile) to an oral glucose
challenge. These ﬁndings led to the sug-
gestion that insulin resistance and hyper-
insulinemia can be dissociated, exist in
isolation from one another, and play dif-
ferent pathogenic roles in the genesis of
theclinicalsyndromesassociatedwiththe
two abnormalities. On the other hand,
these authors did not address certain is-
sues. Speciﬁcally, in their analyses they
separated individuals into quartiles of in-
sulin resistance and insulin response but
did not provide information as to either
the percentage of insulin-resistant indi-
viduals in the lowest quartile of insulin
response or the percentage of insulin-
sensitive individuals in the highest quar-
tile of insulin response.
To better understand how discordant
insulin resistance and hyperinsulinemia
are, we quantiﬁed the percentage of indi-
viduals in quartiles of insulin response by
quartiles of insulin sensitivity. In addi-
tion, to evaluate the differential clinical
impact of insulin resistance and hyperin-
sulinemia, we compared cardiovascular
disease (CVD) risk factors in individuals
within the same quartile of insulin sensi-
tivity but with differing insulin response
levels.
RESEARCH DESIGN AND
METHODS— Study subjects in-
cluded 446 individuals who had partici-
pated in our research studies from 1990
to1998andwhohadgiveninformedcon-
sent. All study protocols were approved
by Stanford’s Institutional Review Board.
Individuals considered for inclusion were
nondiabetic (15) and in good general
health with no history of coronary artery,
kidney, or liver disease. All individuals
had the following procedures: measure-
ment of height, weight, and systolic and
diastolic blood pressures; lipid assess-
ment; oral glucose tolerance test; and in-
sulin suppression test to measure insulin
sensitivity. Initially, 490 individuals were
identiﬁed, but 44 were removed for miss-
ingdata.Wehadpublishedanarticlepre-
viously in which we described the
distribution of insulin sensitivity in the
entire population of 490 individuals, as
wellastherelationshipbetweenthequan-
titative estimate of insulin-mediated glu-
cose disposal and several different
surrogate estimates of this variable (16).
All metabolic testing was performed
in Stanford’s General Clinical Research
Center after subjects fasted for 12 h. Dur-
ing the oral glucose tolerance test, plasma
glucoseandinsulinweremeasuredbefore
(fasting) and 30, 60, 120, and 180 min
afteringestionof75goforalglucose(16).
Individuals were classiﬁed as having im-
paired glucose tolerance (IGT) if their 2-h
glucose value was between 7.8 and 11.1
mmol/l. Lipid measurements were per-
formed by the core laboratory at Stanford
and included total cholesterol, triglycer-
ide, and HDL cholesterol concentrations.
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culated by the Friedewald formula.
Insulin sensitivity was measured di-
rectly with the modiﬁed version (17) of
the insulin suppression test, initially in-
troduced and validated by our research
group (18). The values for insulin sensi-
tivity obtained with this approach are
highlycorrelated(r0.9)withthehyper-
insulinemic-euglycemic clamp technique
(19). In brief, after an overnight fast, an
intravenouscatheterwasplacedineachof
the subject’s arms. One arm was used for
the administration of a 180-min infusion
of octreotide (0.27 g   m
2   min
1),
insulin (32 mU   m
2   min
1), and glu-
cose (267 mg   m
2   min
1); the other
arm was used for collecting blood sam-
ples.Bloodwasdrawnat10-minintervals
from 150 to 180 min of the infusion to
determine the steady-state plasma glu-
cose (SSPG) and insulin concentrations.
Because steady-state insulin concentra-
tions are similar in individuals, the SSPG
concentration provides a direct measure of
the ability of insulin to mediate disposal of
an infused glucose load; therefore, the
higher the SSPG concentration, the more
insulin resistant the individual is.
As there are no objective methods to
classify individuals as insulin resistant or
insulin sensitive, we divided individuals
into quartiles of insulin sensitivity (SSPG
concentration) to maintain consistency
with the recent article by Ferrannini et al.
(14). With this approach, a higher quar-
tile indicates a greater degree of insulin
resistance, i.e., quartile 4 contains the
25% most insulin-resistant individuals
and quartile 1 contains the most insulin-
sensitive individuals.
Insulin response was quantiﬁed by
calculating the insulin area under the
curve (over 3 h) by the trapezoidal
method, and the subjects were again di-
vided into quartiles based on the magni-
tude of their total integrated insulin
response to glucose. Quartile 1 had the
lowest insulin response, and quartile 4
had the highest response.
To evaluate the degree of concor-
dance between insulin sensitivity and in-
sulin response, we quantiﬁed the
percentage of individuals in each of the
four insulin response quartiles that were
present within each of the four SSPG
quartiles. In addition, in insulin-sensitive
(SSPG quartile 1) and insulin-resistant
individuals (SSPG quartile 4), we also
compared CVD risk factors in those
with different insulin response but
within the same SSPG quartile to assess
the independent impact of insulin on
CVD risk factors.
Statistical analyses were performed
using SAS (version 9.1; SAS Institute,
Cary, NC). Triglyceride and insulin con-
centrations were log-transformed to ob-
tain a more normal distribution for
statistical tests; median and interquartile
ranges are presented in the RESULTS.
Trends in baseline characteristics among
SSPG quartiles were analyzed using
ANOVA for continuous measures and the
Cochrane-Armitage test for proportions.
Independent t tests were used to compare
differences between the two groups.
RESULTS— Table 1 shows the demo-
graphic and metabolic characteristics of
the individuals divided into quartiles of
insulin sensitivity. Individuals in SSPG
quartile 4 were somewhat older and
heavier, but the groups were not different
intermsofsexandethnicdistribution.As
insulin resistance (SSPG) increased, the
proportion of individuals with IGT in-
creased. There was also a dramatic in-
crease in the median insulin response,
with the values in SSPG quartile 4 being
249% higher than those in SSPG quartile
1. Fasting plasma insulin concentrations
also increased in parallel with degree of
insulin resistance. In addition, the inter-
quartile ranges did not overlap between
these two extreme groups. Finally, the
more insulin resistant the group was, the
more unfavorable the CVD risk proﬁle
was. Thus, individuals in SSPG quartile
4 had higher blood pressures, and all
components of the lipid panel also in-
creased or, in the case of HDL choles-
terol, decreased.
The results in Fig. 1A demonstrate
that the relationship between insulin re-
sistance (SSPG) and insulin response was
bestexpressedbyanexponentialfunction
(r  0.76, P  0.001) with no difference
by sex (male, r  0.77; female, r  0.76).
When insulin response was log-
transformed,therelationshipbetweenin-
Table 1—Baseline characteristics of individuals by SSPG quartile
SSPG quartile 1:
4.8 mmol/l
SSPG quartile 2:
4.8–7.7 mmol/l
SSPG quartile 3:
7.8–11.7 mmol/l
SSPG quartile 4:
11.7 mmol/l Ptrend
n 112 111 112 111
Age (years) 45  12 48  13 49  14 52  12 0.001
BMI (kg/m
2) 24  32 5  42 7  43 0  4 0.001
Sex (% male) 46 48 41 52 0.53
Non-Hispanic white 92 88 83 86 0.12
IGT 2 5 13 38 0.001
Insulin response (pmol  
l
1   3h
1)
570 (433–730) 780 (635–1,030) 1,093 (904–1,412) 1,991 (1,441–2,766) 0.001
Fasting glucose (mmol/l) 4.8  0.6 5.0  0.6 5.1  0.6 5.4  0.7 0.001
Fasting insulin (pmol/l) 49 (35–68) 63 (49–76) 76 (56–90) 118 (90–160) 0.001
Total cholesterol (mmol/l) 4.6  0.9 4.9  0.9 4.8  0.9 5.2  0.9 0.001
Triglyceride (mmol/l) 0.77 (0.60–0.99) 0.98 (0.79–1.39) 1.26 (0.87–1.65) 1.80 (1.38–2.42) 0.001
HDL cholesterol (mmol/l) 1.4  0.4 1.3  0.4 1.2  0.3 1.1  0.3 0.001
LDL cholesterol (mmol/l) 2.8  0.8 3.0  0.8 3.0  0.8 3.2  0.8 0.001
Systolic blood pressure (mmHg) 120  18 123  18 127  19 140  20 0.001
Diastolic blood pressure
(mmHg)
72  10 75  11 78  11 87  11 0.001
Data are means  SD, median (interquartile range), or percent.
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equally well represented by a linear func-
tion (r  0.76, P  0.001) (Fig. 1B). This
relationship was stronger than that be-
tween SSPG and fasting insulin (r 
0.61), 2-hour insulin (r  0.70), and
2-hour integrated insulin response (r 
0.74) (t 4 for all comparisons, degrees
of freedom 443, P  0.001). The strong
relationship between SSPG and insulin
response remained even when individu-
alswithIGTwereexcluded(r0.74,P
0.001, n  381).
The close relationship between insu-
lin resistance and insulin response is also
highlighted in Table 2, which shows the
proportion of individuals in each of the
four SSPG quartiles as a function of their
insulin response quartile. In the most in-
sulin-sensitive quartile (SSPG quartile 1),
64% had the lowest insulin response
(quartile 1) and 28% had the second low-
est insulin response (quartile 2), with a
total of 92% in the bottom two insulin
response quartiles. No one was in the
highestinsulinresponsequartile(quartile
4). In the most insulin-resistant quartile
(SSPG quartile 4), 71% were in the high-
est insulin-response quartile (quartile 4)
and 24% were in the second highest
(quartile 3), with a total of 95% in the top
two quartiles. Only 1% was in the lowest
insulin response quartile. Excluding indi-
viduals with IGT did not substantially
change these ﬁndings, i.e., 92% of indi-
viduals in the two most insulin-resistant
quartiles were in the two quartiles with
thehighestinsulinresponse,andonly1%
of insulin-resistant individuals were in
the lowest insulin response quartile.
The data in Table 2 emphasize that
there were relatively few insulin-sensitive
individuals(SSPGquartile1)whoseinsu-
lin responses were in the two highest
quartiles (8%) and very few insulin-
resistant individuals (SSPG quartile 4)
with insulin responses in the two lowest
quartiles (5%). Therefore, to further pur-
suetherelationshipbetweendegreeofin-
sulin sensitivity, magnitude of insulin
response, and CVD risk, we compared
differences in CVD risk factors between
those with the lowest insulin responses
(quartiles 1 and 2) within the most insu-
lin-sensitive quartile (SSPG quartile 1), as
well as between individuals with the two
highest insulin responses (quartiles 3 and
4) within the most insulin-resistant quar-
tile (SSPG quartile 4) (Table 3).
Focusing ﬁrst on insulin-sensitive in-
dividuals (SSPG quartile 1), by selection,
insulin response was statistically different
in the two insulin response groups. In ad-
dition, SSPG concentration was signiﬁ-
cantly higher in individuals with the
greaterinsulinresponse(insulinresponse
quartile 2 versus quartile 1) despite being
within the same insulin sensitivity quar-
tile. Finally, there were also marginally
higher concentrations of fasting insulin,
Figure 1—Relationship between insulin resistance (SSPG) and insulin response was best ex-
pressed as an exponential function (A) or a linear function when insulin response (insulin AUC)
was log-transformed (B).
Table 2—Proportion of individuals in insulin response quartiles by SSPG quartiles
Insulin response
SSPG
quartile 1
SSPG
quartile 2
SSPG
quartile 3
SSPG
quartile 4
n 112 111 112 111
Quartile 1: 648
(pmol   l
1   3h
1)
64 27 8 1
Quartile 2: 648–969
(pmol   l
1   3h
1)
28 44 24 4
Quartile 3: 970–1,514
(pmol   l
1   3h
1)
82 04 82 4
Quartile 4: 1,514
(pmol   l
1   3h
1)
0 9 20 71
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0.08)inthehigherinsulinresponsequar-
tile (quartile 2).
In the insulin-resistant group (SSPG
quartile 4), as above, the insulin re-
sponses were signiﬁcantly different by se-
lection.Thoseindividualswiththehigher
insulin response (insulin response quar-
tile 4 versus 3) also had higher SSPG and
fastinginsulinconcentrationsandalower
HDL cholesterol concentration.
We also repeated our major analyses
withtheinclusioncriteriausedinarecent
articleaddressingthesameissue(14):age
30–60 years, arterial blood pressure
140/90 mmHg, total serum cholesterol
7.8 mmol/l, and serum triglycerides
4.6 mmol/l. This decreased our study
population to 227. The relationship be-
tween SSPG and insulin response (log-
transformed) remained similar (r  0.78,
P  0.001). Within the top insulin-
resistant quartile, 63% were in insulin re-
sponsequartile4and30%wereininsulin
response quartile 3, with a total of 93% in
the top two insulin response quartiles.
CONCLUSIONS — In this study of
nondiabetic individuals, we identiﬁed a
highly signiﬁcant correlation between in-
sulin resistance and insulin response (r 
0.76), indicating that the relationship be-
tweenthesetwovariablesisacloseone.In
this context, it should be recognized that
theplasmainsulinresponsetoanoralglu-
cose challenge will vary as a function of
the interplay between several biological
systems,including,ataminimum,degree
of insulin resistance, insulin secretory
function, plasma glucose concentration,
and insulin removal rate from plasma.
The relationship between insulin resis-
tanceandinsulinresponseisfurthercom-
pounded by the inherent error in making
either measurement. We have previously
shown that SSPG concentration, when
measured twice in the same individual,
varied by 10–30% in 25% of those
studied (19), and the plasma insulin con-
centration 2 h after a 75-g oral glucose
load varied by 20% in two-thirds of the
individualsstudiedwhenrepeatmeasure-
ments were made 2 days apart (20). In
view of these considerations, the fact that
the relationship between insulin resis-
tanceandinsulinresponseisnotaperfect
one is hardly surprising. Indeed, we
would argue that what is surprising is
how strong the relationship seems to be
(r  0.76) and how rare (5%) it is to ﬁnd
insulin-resistant individuals (SSPG quar-
tile 4) who have an insulin response be-
low the median for this population or
insulin-sensitive (SSPG quartile 1) indi-
viduals who have an insulin response
above the median (8%).
Given the results of this analysis, it is
difﬁcult to ignore the possibility that in-
sulin resistance and hyperinsulinemia
tightlycoexist.However,arecentstudyin
aEuropeanpopulationchallengedthede-
gree of association between these two
variables (14). Although these authors
found insulin sensitivity and insulin re-
sponse to be closely associated (Spear-
man’s rank correlation  0.63 in men
and 0.50 in women), they argued that
each could be found in isolation in the
population.Thisconclusionwasbasedon
the fact that only 60% of the individuals
inthemostinsulin-resistantquartilewere
also in the highest insulin response quar-
tile. However, no information was pro-
vided regarding the proportion in the
otherinsulinresponsequartiles.Ascanbe
seeninTable2,thedistributionofinsulin
response is not evenly dispersed within
the top insulin-resistant quartile (SSPG
quartile 4) but is skewed to the top two
insulin response quartiles. Certainly,
100% of the most insulin-resistant indi-
vidualsarenotinthetopinsulinresponse
quartile, but 95% are in the top two quar-
tiles. The same can be said in reverse: al-
though not all insulin-sensitive
individuals (SSPG quartile 1) are in the
lowest insulin response quartile (64%),
92% are in the lowest two quartiles.
It is difﬁcult to compare our results
to those of the European cohort, as they
did not assess the distribution of insulin
response in the same manner. Further-
more, our populations seem to be some-
what different. We had more individuals
who were in both the highest insulin-
resistance and highest insulin-response
quartilesthantheEuropeanstudydid(71
vs.60%).Inaddition,thervaluebetween
Table 3—Comparison of cardiovascular risk factors in individuals with different insulin responses but within the same insulin sensitivity
quartile
SSPG quartile 1: insulin sensitive SSPG quartile 4: insulin resistant
Insulin response
quartile 1
Insulin response
quartile 2 P value
Insulin response
quartile 3
Insulin response
quartile 4 P value
n 72 31 27 79
Insulin response
(pmol   l
1   3h
1)
484 (390–552) 738 (689–853) 0.001 1,233 (1,075–1,422) 2,441 (1,870–2,931) 0.001
SSPG (mmol/l) 3.3  0.8 3.8  0.7 0.004 13.5  1.5 14.8  1.7 0.001
Age (years) 45  12 46  11 0.93 49  14 53  11 0.24
Sex (% male) 46 45 0.95 59 51 0.44
Non-Hispanic white 92 94 0.74 89 86 0.71
BMI (kg/m
2) 23  32 4  3 0.47 29  53 1  4 0.07
Fasting glucose (mmol/l) 4.8  0.6 4.9  0.4 0.34 5.4  0.8 5.5  0.6 0.65
Fasting insulin (pmol/l) 42 (35–56) 56 (42–69) 0.08 97 (76–111) 132 (104–181) 0.001
Total cholesterol (mmol/l) 4.5  0.7 4.8  1.0 0.08 5.2  0.9 5.2  0.9 0.78
Triglyceride (mmol/l) 0.75 (0.60–0.92) 0.93 (0.67–1.10) 0.08 1.75 (1.25–2.25) 1.81 (1.41–2.46) 0.18
HDL cholesterol (mmol/l) 1.5  0.4 1.4  0.4 0.75 1.3  0.3 1.1  0.2 0.001
LDL cholesterol (mmol/l) 2.7  0.7 3.0  1.0 0.12 3.1  0.8 3.2  0.8 0.73
Systolic blood pressure (mmHg) 122  19 117  16 0.21 143  23 140  19 0.52
Diastolic blood pressure (mmHg) 72  10 74  10 0.33 88  12 86  11 0.54
Data are means  SD, median (interquartile range), or percent.
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was higher in our study. On the other
hand, when inclusion criteria similar to
those in the European study were used,
we had similar proportions of individuals
in both the top insulin resistance and in-
sulin response quartiles (63%). However,
the total in the top two insulin response
quartiles stayed high (93%). In addition,
the r value remained at 0.78 between in-
sulin sensitivity and insulin response.
Although the degree of insulin resis-
tance contributes strongly to insulin re-
sponse, we understand that many factors
affect the variance in insulin response as
discussed above. Another factor is obe-
sity, which increases insulin response by
enhancing insulin secretion (21–23) and
decreasing insulin clearance (24,25), es-
pecially in insulin-resistant individuals
(4).Thisinstancecanbeseeninthisstudy
when individuals with higher insulin re-
sponsetendedtobemoreobesethanoth-
ers, even within the same SSPG quartile
(Table 3), a ﬁnding that was most evident
in the top insulin-resistant quartile (SSPG
quartile 4). On the other hand, even in
this instance, insulin resistance is also
higher in the individuals with higher in-
sulin response. Therefore, it is again dif-
ﬁcult to separate insulin response from
insulin sensitivity.
Because of this collinearity, it is difﬁ-
cult to deﬁne the putative effects of insu-
lin resistance versus compensatory
hyperinsulinemia on CVD risk factors,
and the data in Table 3 illustrate this
point. In the most insulin-sensitive quar-
tile(SSPGquartile1),whenwecompared
CVD risk factors in those in the lowest
insulin response quartile to those of indi-
viduals in the next highest insulin re-
sponse quartile, the two groups differed
only in degree of insulin resistance.
Similarly, in the most insulin-resistant
quartile (SSPG quartile 4), SSPG con-
centrations were higher in those with
the greatest insulin response (quartile
4) compared with those in insulin re-
sponse quartile 3. However, other than
a lower HDL cholesterol concentration
in those with the higher insulin re-
sponse, there were no signiﬁcant differ-
ences in CVD risk factors between the
twoinsulinresponsegroups.Thesedata
do not support a role of hyperinsulin-
emia, independent of insulin resistance,
in the development of known CVD risk
factors.Itshouldalsobenotedthateven
in the European cohort discussed
above, insulin resistance clustered with
higher insulin response, higher triglyc-
erides, and lower HDL cholesterol dur-
ing factor analysis.
In summary, insulin resistance and
hyperinsulinemia are closely linked. Al-
though insulin sensitivity does not ac-
count for 100% of the variance in insulin
response, it is difﬁcult to discern an inde-
pendent impact of hyperinsulinemia on
CVD risk factors associated with insulin
resistance (26). Perhaps the simplest
pathophysiological approach is to view
insulin resistance/compensatory hyperin-
sulinemia as one entity in nondiabetic in-
dividuals, rather than attempting by
statistical methods to come to conclu-
sionsastowhichabnormalityiscausedby
insulin resistance and which is caused by
hyperinsulinemia.
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